CoChat

Muscle wasting in disease: molecular mechanisms and promising therapies

Cohen, Shenhav, Nathan, James A., Goldberg, Alfred L. · 2015 · Nature Reviews Drug Discovery

The DOI matches its Crossref record; 255 of the 257 references it cites were found in a registry or an index.

Abstract

Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.

Overview

Integrity signals

Registry

Crossref · 10.1038/nrd4467

Cites

255 of 255 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

1 retracted

Show all 255 references

Research works printed but not linked: 1

  1. Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35–46 (2007). · DOI · Paper page

Cited by

Items 901–1,000 of 1,000

Metadata

Authors
Cohen, S., Nathan, J. A., & Goldberg, A. L.
Affiliations
  • Technion – Israel Institute of Technology (IL)
  • University of Cambridge (GB)
  • Harvard University (US)
Corresponding author
  • Cohen, Shenhav
  • Goldberg, Alfred L.
Venue
Nature Reviews Drug Discovery
Published
2014-12-31
Volume
14
Issue
1
Pages
58-74
ISSN
  • 1474-1776 (ISSN-L)
  • 1474-1784
OpenAlex
W1998867833
Cited by
1,089
References
257
Citations by year
2026: 75 · 2025: 92 · 2024: 92 · 2023: 111 · 2022: 110 · 2021: 111 · 2020: 117 · 2019: 88 · 2018: 91 · 2017: 86 · 2016: 79 · 2015: 36
FWCI
6.32
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Drug Discovery (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust (100140, 102770, 102770/Z/13/Z)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055255, R01AR055255)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
Keywords
muscle atrophy, sarcopenia, cancer cachexia, sepsis, denervation, immobilization, protein synthesis, protein degradation, myostatin, cytokines, exercise therapy, therapeutic agents, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, heart failure, Cushing's syndrome
MeSH terms
Animals, Humans, Muscular Atrophy, Myofibrils, Quality of Life, Signal Transduction, Sepsis, Wasting Syndrome, Myostatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.